SAN DIEGO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.